Fabrication Scaffold with High Dimensional Control for Spheroids with Undifferentiated iPS Cell Properties.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
11 01 2023
Historique:
received: 06 11 2022
revised: 04 01 2023
accepted: 09 01 2023
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 25 1 2023
Statut: epublish

Résumé

Spheroids are expected to aid the establishment of an in vitro-based cell culture system that can realistically reproduce cellular dynamics in vivo. We developed a fluoropolymer scaffold with an extracellular matrix (ECM) dot array and confirmed the possibility of mass-producing spheroids with uniform dimensions. Controlling the quality of ECM dots is important as it ensures spheroid uniformity, but issues such as pattern deviation and ECM drying persist in the conventional microstamping method. In this study, these problems were overcome via ECM dot printing using a resin mask with dot-patterned holes. For dot diameters of φ 300 μm, 400 μm, and 600 μm, the average spheroid diameters of human iPS cells (hiPSCs) were φ 260.8 μm, 292.4 μm, and 330.7 μm, respectively. The standard deviation when each average was normalized to 100 was 14.1%. A high throughput of 89.9% for colony formation rate to the number of dots and 89.3% for spheroid collection rate was achieved. The cells proliferated on ECM dots, and the colonies could be naturally detached from the scaffold without the use of enzymes, so there was almost no stimulation of the cells. Thus, the undifferentiated nature of hiPSCs was maintained until day 4. Therefore, this method is expected to be useful in drug discovery and regenerative medicine.

Identifiants

pubmed: 36672213
pii: cells12020278
doi: 10.3390/cells12020278
pmc: PMC9857117
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Biosci Bioeng. 2012 Sep;114(3):360-3
pubmed: 22677065
Ann Vasc Surg. 1999 Mar;13(2):141-50
pubmed: 10072452
Am J Pathol. 2022 May;192(5):738-749
pubmed: 35181335
Acta Biomater. 2019 Mar 1;86:148-157
pubmed: 30586645
Gene. 2022 Dec 15;845:146855
pubmed: 36058497
Lab Chip. 2016 Jul 5;16(14):2636-43
pubmed: 27327102
Bioprinting. 2019 Sep;15:
pubmed: 31457109
J Biosci Bioeng. 2014 Oct;118(4):455-60
pubmed: 24742630
Toxicol In Vitro. 2018 Aug;50:86-94
pubmed: 29476884
Sci Rep. 2014 Mar 27;4:4488
pubmed: 24671046
Stem Cell Reports. 2022 Aug 9;17(8):1874-1888
pubmed: 35803261
Biomaterials. 2011 Sep;32(26):6052-8
pubmed: 21640378
Biomaterials. 2022 Jun 17;287:121638
pubmed: 35921729
Biomaterials. 2009 Jun;30(16):3020-7
pubmed: 19304321
Biomaterials. 2019 Mar;197:194-206
pubmed: 30660995
Anal Biochem. 2011 Dec 15;419(2):348-50
pubmed: 21910965
Curr Opin Genet Dev. 2022 Aug;75:101944
pubmed: 35785592
Biotechnol Adv. 2011 Nov-Dec;29(6):739-67
pubmed: 21821113
Elife. 2022 Jan 12;11:
pubmed: 35018887
Regen Ther. 2019 Jan 02;10:69-76
pubmed: 30623004
Biotechnol Bioeng. 2007 Oct 15;98(3):694-700
pubmed: 17385742
Acta Biomater. 2016 Sep 15;42:341-350
pubmed: 27370904
Biomaterials. 2010 Jan;31(3):413-9
pubmed: 19811820
Int J Mol Sci. 2021 Aug 12;22(16):
pubmed: 34445363
Mater Sci Eng C Mater Biol Appl. 2021 Dec;131:112458
pubmed: 34857315
Acta Biomater. 2021 Nov;135:234-242
pubmed: 34389482
Cancers (Basel). 2020 Sep 24;12(10):
pubmed: 32987868
J R Soc Interface. 2017 Feb;14(127):
pubmed: 28202590
Cell. 2016 May 19;165(5):1238-1254
pubmed: 27118425
Biotechnol Appl Biochem. 2007 Feb;46(Pt 2):73-84
pubmed: 17227284
Biomaterials. 2003 Dec;24(28):5139-44
pubmed: 14568430
Transl Res. 2022 Dec;250:1-17
pubmed: 35750295
Nat Nanotechnol. 2010 Apr;5(4):291-6
pubmed: 20228788
Biomaterials. 2022 Jun 1;287:121614
pubmed: 35688027

Auteurs

Hidetaka Togo (H)

Graduate School of Biology-Oriented-Science and Technology, Kindai University, 930 Nishimitani, Kinokawa 649-6493, Wakayama, Japan.

Kento Terada (K)

Department of Obstetrics and Gynecology, Graduate School of Medicine, Mie University, 2-174 Edobashi, Tsu 514-8507, Mie, Japan.

Akira Ujitsugu (A)

Faculty of Biology-Oriented-Science and Technology, Kindai University, 930 Nishimitani, Kinokawa 649-6493, Wakayama, Japan.

Yudai Hirose (Y)

Graduate School of Biology-Oriented-Science and Technology, Kindai University, 930 Nishimitani, Kinokawa 649-6493, Wakayama, Japan.

Hiroki Takeuchi (H)

Department of Obstetrics and Gynecology, Graduate School of Medicine, Mie University, 2-174 Edobashi, Tsu 514-8507, Mie, Japan.

Masanobu Kusunoki (M)

Graduate School of Biology-Oriented-Science and Technology, Kindai University, 930 Nishimitani, Kinokawa 649-6493, Wakayama, Japan.
Faculty of Biology-Oriented-Science and Technology, Kindai University, 930 Nishimitani, Kinokawa 649-6493, Wakayama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH